Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Semaglutide is available under the brand names Ozempic, Rybelus, and Wegovy , manufactured by Novo Nordisk, and is FDA-approved for various conditions
& Griffiths, R
Exercise
Ozempic has gained popularity as a weight loss treatment because of its ability to provide lasting results for people struggling with weight management, particularly those who have not had success with traditional weight loss methods
Approval (2017) FDA News Release: FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight (March 08, 2024) Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation (May 17, 2025) Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Oral Semaglutide Versus Subcutaneous Liraglutide And Placebo In Type 2 Diabetes (PIONEER 4): A Randomised, Double-Blind, Phase 3a Trial Wegovy Dosing Schedule Ozempic Dosing Schedule Rybelsus Dosing Schedule
US$ 26.71
US$ 26.30
US$ 23.85
